SAFE Banking Act Explained for Cannabis Payments

The SAFE Banking Act is a pending bill, not a law, as of July 2026. It has been reintroduced yet again, and it still has to clear both chambers of Congress before anything changes. So if you run a cannabis or cannabis-related business, the honest headline is that the rules governing your payments have not moved. This post explains what the bill would actually do, what it would not do, and why card acceptance is a separate problem from banking.

Key takeaways

• The SAFE Banking Act is not law. The current version, H.R. 9471, was reintroduced on June 25, 2026 and sits in House committee (GovInfo, 2026). Earlier versions passed the House seven times but never reached a Senate floor vote (Merkley, 2026; GovInfo, 2026).
• The bill is about depository banking, meaning checking accounts, loans, and insurance. It does not rewrite the card networks’ rules, so it would not by itself let a dispensary accept Visa or Mastercard for direct THC sales.
• It is not legalization. The bill would not change what is legal to sell or remove cannabis from federal control.
• You do not have to wait for it. Ancillary, B2B, and hemp-derived CBD businesses can usually be reviewed for processing today, based on documentation rather than pending law.

Has the SAFE Banking Act passed?

No. As of July 2026 the SAFE Banking Act is a proposed bill that has not become law. The most recent version in the House, H.R. 9471, was introduced on June 25, 2026 by Representative David Joyce and referred to committee the same day (GovInfo, 2026). A companion measure was reintroduced in the Senate by a bipartisan group including Jeff Merkley, Lisa Murkowski, Steve Daines, and Elizabeth Warren (Merkley, 2026). “Referred to committee” is the very first step, not the finish line.

The bill also has a long history of stalling. Earlier versions passed the House seven separate times with bipartisan support, yet none ever got a floor vote in the Senate (Merkley, 2026; GovInfo, 2026). That pattern matters more than any single reintroduction. A bill can be popular in one chamber and still never reach the President’s desk. Support is real, but so is the track record of the bill dying between the two chambers.

You may also see it called the SAFER Banking Act, a later renamed version of the same effort. The name has shifted across sessions of Congress, and it has picked up backing from groups like the American Bankers Association, which sent a letter urging passage on July 1, 2026 (Forbes, 2026). None of that changes the current status. Until a version passes both chambers and is signed, it is advocacy, not law, and it should not be described as upcoming or about to take effect.

What would the SAFE Banking Act actually do?

The bill targets one specific problem, which is that banks are afraid to serve cannabis businesses. Cannabis remains illegal under federal law even in states that have legalized it. Because of that gap, a bank that opens an account for a state-licensed cannabis operator can face federal penalties, anti-money-laundering scrutiny, and reporting burdens. Many banks decide the risk is not worth it and turn the whole industry away (Forbes, 2026).

The SAFE Banking Act would reduce that penalty risk. In plain terms, it would tell federal regulators they cannot punish a bank simply for providing normal financial services to a legitimate, state-sanctioned cannabis business. That protection would extend past banks to certain credit unions, insurers, and lenders that work with the industry. The goal is to pull a mostly cash business into the regulated banking system, which supporters argue is safer for everyone.

Depository banking is the core of it. That means checking accounts, payroll, loans, and insurance. For an operator who currently pays staff and vendors out of a safe full of cash, gaining a plain bank account would be a genuine change. What the bill does not touch, though, is just as important, and it is where a lot of the confusion starts.

Would the SAFE Banking Act let cannabis businesses take credit cards?

Not by itself, and this is the point most coverage skips. The card networks, mainly Visa and Mastercard, run their own private rulebooks. Those rules currently prohibit processing payments for federally illegal products, and a bank-focused law does not rewrite them. So even if the SAFE Banking Act became law tomorrow, a dispensary selling direct THC would not automatically be able to accept a Visa card at checkout.

This is why so many cannabis retailers today lean on cash, ATM-style cashless workarounds, or bank-debit rails instead of ordinary card acceptance. The block is not only the bank. It is also the network layer sitting above the bank, plus the acquiring bank, which is the institution that actually connects a merchant to those networks and answers for the risk. The SAFE Banking Act speaks to the deposit side of that chain, not the network rules that decide what a card can be used for.

The practical takeaway is to separate two questions that often get blurred together. One is whether a cannabis business can hold a bank account. The other is whether it can accept mainstream credit cards for its products. The pending bill mostly speaks to the first. The second stays governed by network policy and by how each business is underwritten, which is a review of the specific risk a merchant carries. Treating a banking bill as a card-acceptance fix leads to disappointment.

Why cannabis payments stay hard even where states have legalized

Payment access is a risk decision, not a legality vote. That is the frame that actually predicts what a processor will do. A business can be fully licensed and compliant in its state and still get declined, because the processor is pricing federal exposure, reputation risk, and chargeback history, not casting a vote on whether the product should be legal. This site prices payment risk. It does not offer legal advice, and legal questions belong with your own counsel.

That distinction is why blanket declines hit even careful operators. Mainstream processors like Stripe, Square, and PayPal tend to reject the entire category at signup rather than sort good operators from bad ones. Worse, the harder blow often lands after approval, when an aggregator boards an account, sees a pattern it dislikes, and drops a rolling reserve or freezes the balance. A rolling reserve is money the processor holds back from your own sales, and a freeze can cut off cash you already earned right when you need it for payroll.

The SAFE Banking Act, if it passed, might ease some of the bank-level fear over time. It would not erase the risk-based underwriting that decides your terms. Card networks would still set their rules, acquirers would still weigh your dispute history, and a business that runs hot on chargebacks would still draw a reserve. Reading the bill as a switch that makes cannabis payments easy overstates what any banking law can do.

How cannabis-related businesses get processing today

You do not have to wait on Congress, because a large share of the cannabis economy already qualifies for processing now. The key is that the industry is not one risk bucket. Ancillary businesses, meaning companies that sell products or services around cannabis rather than the plant itself, look very different to an underwriter than a direct-THC seller. So do business-to-business suppliers and hemp-derived CBD brands.

Here is where approval is realistic today with the right documentation:

• Ancillary and B2B suppliers. Packaging, equipment, cultivation supply, software, and education businesses can usually be reviewed for card and invoice processing, often with B2B invoicing and interchange optimization that fits larger tickets.
• Hemp-derived CBD and hemp ecommerce. Products sold within Farm Bill limits, meaning the federal law that allows hemp with only a trace level of THC, can be reviewed when backed by certificates of analysis, which are lab reports confirming what is in the product.
• Bank-debit and ACH rails. ACH processing, which moves money directly between bank accounts rather than over card networks, can matter for cannabis-adjacent businesses that face constrained banking access.

What separates an approval from a decline is underwriting that reads your actual model instead of the category label. That is the whole purpose of cannabis and CBD merchant accounts built for this space, where ancillary, B2B, CBD, and hemp risk are scored separately rather than swept into one rejection. If a prior processor already dropped you and left a mark, there are still options after a MATCH or TMF listing, the industry databases that flag terminated merchants.

What to watch, and what to do now

Track the bill by all means, but plan as if nothing changes, because as of July 2026 nothing has. Watch for one thing above the rest, which is whether any version finally gets a Senate floor vote after seven House passages and none in the Senate. That is the wall it keeps hitting. A House committee referral, another reintroduction, or a supportive letter is not that milestone, and it should not change how you run your business this quarter.

In the meantime, sort your own situation honestly. If you are ancillary, B2B, or a compliant hemp or CBD seller, you are likely reviewable for processing today with clean documentation. If you sell direct THC, understand that card acceptance stays constrained by network rules that a banking bill does not touch, so cash and bank-debit paths remain the realistic tools. Either way, the durable move is to get underwriting that prices your specific risk, rather than betting your cash flow on a bill that has stalled many times before.